BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Legislator Seeks Changes In University of Georgia Research Foundation, Inc. Licensing


9/2/2008 6:16:39 AM

Atlanta Business Chronicle -- A Georgia legislator wants to examine how the state university system governs its intellectual property — an issue prompted by The University of Georgia Research Foundation Inc.’s dealings with a giant pharmaceutical company.

State Sen. Doug Stoner, D-Cobb, in an Aug. 22 letter to university system Chairman Richard L. Tucker, said the university should have a uniform policy “to determine the monetary implications of inventions prior to the signing of any agreement to market and sell the product.”

Stoner, though in the minority party, said he thinks the Senate could hold hearings on the matter in the next legislative session.

His letter comes after revelations that the University of Georgia Research Foundation, which governs the university’s licensing of patents, may have lost as much as $222 million by renegotiating a deal to license the blockbuster drug Restasis without the knowledge of its creator, UGA researcher Renee Kaswan.

Kaswan, who later sued the foundation and pharmaceutical giant Allergan Inc., said the new agreement cost her nearly $100 million.

Stoner said that if Kaswan’s allegations are true, then the state government should become more involved.

He wrote: “To learn that our Flagship University passed up such a sum when, at the time, we were looking at budget shortfalls in the State at large was astonishing.”

He also sent that letter to Sen. John Wiles, also of Cobb County, who sits on the Appropriations Committee and chairs its Higher Education Subcommittee, and Sen. Seth Harp who chairs the Higher Education Committee.

Copies also went to Lt. Gov. Casey Cagle, regent Kessell Stelling Jr. and Chancellor Erroll Davis.

He is the third state legislator to write a letter on this issue. He said he has had conversations with Harp and Wiles on the matter.

Harp said he did not think the issue would get much attention at the next session, as the state must deal with a huge budget shortfall. He said it was “not very high on the priority list.”

Stoner also is concerned about the state’s reputation. The Georgia Research Alliance has brought 58 researchers here as part of its Eminent Scholars program. Stoner does not want to jeopardize those efforts.

“Word’s getting around,” he said. “... It concerns me that it could really damage our reputation.”



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->